New Results
In vivo reprogramming leads to premature death due to hepatic and intestinal failure
Alberto Parras, Alba Vílchez-Acosta, Gabriela Desdín-Micó, Calida Mrabti, Cheyenne Rechsteiner, Fabrice Battiston, Clémence Branchina, Kevin Pérez, Christine Sempoux, Alejandro Ocampo
doi: https://doi.org/10.1101/2022.05.27.493700
Alberto Parras
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Alba Vílchez-Acosta
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Gabriela Desdín-Micó
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Calida Mrabti
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Cheyenne Rechsteiner
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Fabrice Battiston
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Clémence Branchina
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Kevin Pérez
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
Christine Sempoux
2Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Alejandro Ocampo
1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland

Article usage
Posted May 27, 2022.
In vivo reprogramming leads to premature death due to hepatic and intestinal failure
Alberto Parras, Alba Vílchez-Acosta, Gabriela Desdín-Micó, Calida Mrabti, Cheyenne Rechsteiner, Fabrice Battiston, Clémence Branchina, Kevin Pérez, Christine Sempoux, Alejandro Ocampo
bioRxiv 2022.05.27.493700; doi: https://doi.org/10.1101/2022.05.27.493700
In vivo reprogramming leads to premature death due to hepatic and intestinal failure
Alberto Parras, Alba Vílchez-Acosta, Gabriela Desdín-Micó, Calida Mrabti, Cheyenne Rechsteiner, Fabrice Battiston, Clémence Branchina, Kevin Pérez, Christine Sempoux, Alejandro Ocampo
bioRxiv 2022.05.27.493700; doi: https://doi.org/10.1101/2022.05.27.493700
Subject Area
Subject Areas
- Biochemistry (8783)
- Bioengineering (6490)
- Bioinformatics (23375)
- Biophysics (11761)
- Cancer Biology (9163)
- Cell Biology (13266)
- Clinical Trials (138)
- Developmental Biology (7419)
- Ecology (11378)
- Epidemiology (2066)
- Evolutionary Biology (15100)
- Genetics (10406)
- Genomics (14017)
- Immunology (9133)
- Microbiology (22084)
- Molecular Biology (8792)
- Neuroscience (47417)
- Paleontology (350)
- Pathology (1421)
- Pharmacology and Toxicology (2483)
- Physiology (3709)
- Plant Biology (8056)
- Synthetic Biology (2213)
- Systems Biology (6019)
- Zoology (1251)